BioHealth Innovation, Inc. (BHI) announced that its Board of Directors has unanimously approved the appointment of MedImmune Sr. Director, Partnering & Strategy, Jarrod Borkat as new Vice Chairman. MedImmune, the global biologics research and development arm of AstraZeneca, is a Founding Partner of BHI and continues to be a leader in building the BioHealth Capital Region. BHI would like to thank Emergent BioSolutions CEO, Daniel J. Abdun-Nabi, for his service as Vice Chairman. He will remain as a member of the Board of Directors. Mr. Abdun-Nabi also previously served as chairman of the Maryland Life Sciences Advisory Board (LSAB) and currently serves on Maryland Governor Larry Hogan’s Excel Board.

“We are looking forward to Jarrod taking this role on the BHI Board of Directors,” said Richard Bendis, BHI President and CEO. “His experience and leadership in the BioHealth Capital Region will play a critical role as we continue to more forward.”

Jarrod Borkat is a 18-year veteran in the biopharmaceutical industry. He joined MedImmune in 2010, where he currently serves as Senior Director, Partnering and Strategy. In this role he is responsible for licensing activities and establishing and overseeing global strategic collaborations relevant to MedImmune. His team led the creation of several high profile and strategic collaborations, including with Johns Hopkins University and the University of Maryland. Previously, Jarrod led the Portfolio Management function for MedImmune, helping the organization optimize its R&D portfolio.

Before joining MedImmune, Jarrod worked at Boehringer Ingelheim (BI) Pharmaceuticals, Inc. for 11 years, rising through the ranks in the sales and commercial organization. During his time at BI, he spent two years in Germany, working at their corporate headquarters, leading the global commercial strategy for their CNS franchise. His last position prior to leaving BI was Director of U.S. Marketing, HIV. Jarrod has won multiple awards throughout his career, including being recognized as an industry “Top 25 Direct-to-Consumer Marketer of the Year” in 2007. He is also active in several industry organizations and has served on industry-related panels at various conferences. Jarrod also serves as a board member on Governor Hogan’s LSAB and Leadership Baltimore.

In addition to his professional accomplishments, Jarrod serves on the Kentlands Board of Trustees and the Kentlands Community Foundation Board. He also ran a marathon on all 7 continents with his father, making them the first father/son duo to have accomplished this challenging endeavor. Jarrod earned an M.B.A. from Kennesaw State University, with concentrations in finance and marketing, and earned a B.S. in Biology from the University of Georgia. He is currently enrolled the Masters in Biotech program at Johns Hopkins University.

About BioHealth Innovation, Inc.

BioHealth Innovation, Inc., is a regional innovation intermediary which supports the transformation of research projects into new business opportunities in partnership with the region’s rich assets, institutions, and entrepreneurial community. BHI achieves this goal by being a catalytic partner in the economic development ecosystem. Learn more at www.biohealthinnovation.org.